TY - GEN AU - Hayslip,John W AU - Simpson,Kit N TI - Cost-effectiveness of extended adjuvant rituximab for US patients aged 65-70 years with follicular lymphoma in second remission SN - 1557-9190 PY - 2008///0819 KW - Aged KW - Antibodies, Monoclonal KW - administration & dosage KW - Antibodies, Monoclonal, Murine-Derived KW - Antineoplastic Agents KW - Antineoplastic Combined Chemotherapy Protocols KW - Chemotherapy, Adjuvant KW - economics KW - Costs and Cost Analysis KW - methods KW - Cyclophosphamide KW - Disease-Free Survival KW - Doxorubicin KW - Female KW - Humans KW - Lymphoma, Follicular KW - drug therapy KW - Male KW - Models, Biological KW - Prednisone KW - Remission Induction KW - Rituximab KW - Survival Rate KW - United States KW - Vincristine N1 - Publication Type: Clinical Trial; Journal Article; Multicenter Study UR - https://doi.org/10.3816/CLM.2008.n.020 ER -